Videos

Anti-Semitism has been rising again around the world, and here's how the past can help us.

This expert panel fields multidisciplinary questions on maskne, compliance, access to care and more.

Acne patients are benefitting from a robust pipeline with treatments that hold promise for increased efficacy and safety. First-in-class additions to the FDA-approved armamentarium, such as the novel antiandrogen clascoterone (Winlevi; Sun Pharma), give dermatologists and pediatricians new tools to combat this skin condition. Speakers offer insights on matching medications to individual patient needs and controlling costs.

Speaking from their unique perspectives, physicians and a psychologist share their success strategies for opening a dialogue with pediatric patients and their families about acne’s sometimes devastating impact on their mental wellbeing and quality of life, danger signals to watch, and why the term “bullying” has no place in the conversation.

Panelists provide pearls on how to make a smarter diagnosis, tailor treatment plans to patients’ lifestyles and preferences, and motivate pediatric patients to adhere to their treatment plan.

Should physicians ask parents to leave the exam room to ensure a pediatric patient’s privacy and comfort level? Or is acne a family matter? Will pediatric patients talk openly about the physical and psychological burdens of this skin condition or does the physician need input from parents? Find out the cues, clues, and conversational tips to get to the roots of acne’s impact.

The initial visit with a pediatric or adolescent patient with acne and their parent or guardian goes beyond obtaining a detailed medical history. The conversation needs to address a broad range of acne’s physical symptoms and psychological effects on the patient and their family. The panelists offered best practices on how to drill down for that information within the limitations of time and scope each individual doctor faces.

Acne may be the most common skin condition in the United States, with various studies estimating 79% to 95% of Americans age 12 to 24 experience at least a minor case, but diagnosing, treating, and managing care for pediatric patients affected by it has never been more complex. Dermatology Times® and its sister brands, Contemporary Pediatrics® and Psychiatric Times™, asked thought leaders across disciplines to share their insights as speakers for this exclusive webinar.

"Before you know what kindness really is you must lose things..."

One doctor shares his musical background and the joys of finding your voice through music.

What climate change sign would you march with?

Important next steps studying once-nightly sodium oxybate and other therapies for narcolepsy treatment.

This is the sad reality: In the first year of COVID-19, there were 20,000 more opioid overdose deaths than years previous.

"He manages like somebody carrying a box that is too heavy, first with his arms underneath..."

West Side Story: entertaining, but also telling.

The potential benefits of integrating once-nightly sodium oxybate into routine clinical practice to help address treatment limitations for patients with narcolepsy.

Don't hide the B sides of life.

"...Love can't block a bullet, but neither can it be shot down..."

One doctor shares how family history and art have inspired him.

Radical hope: knowing the seeming impossibility of the task and still having hope anyways.

Questions raised by a recent paper by Kushida CA, et al., highlighting symptom improvement with once-nightly sodium oxybate in patients with narcolepsy.

Here's why the RAISE study is important and what you need to know to help patients.

"And with one slow blink my reality shifts..."

Sanjai Rao, MD, DFAPA, and Kimberly Garcia, DNP, CRNP provide some advice to clinicians on explaining schizophrenia to patients and caregivers to achieve understanding and therapy adherence.

"We've got all this hope in boxes... we need to let it out."

Takeaways of the REST-ON clinical trial results as presented in Sleep that help clinicians learn more about the management of patients with narcolepsy.

Dr. Sanjai Rao and nurse practitioner Kimberly Garcia explain the barriers patients face in getting treatment with long-acting injectables and how COVID-19 has affected patient care.

Experts discuss the advantages of using the longest-acting injection formulation to treat schizophrenia, and whether there’s a need to discuss LAIs with patients from onset of illness.

How can we enhance our understanding of the human brain?

Which 2021 cover was your favorite?